| Name | N-[4-(3,4-dihydro-1H-isoquinolin-2-yl)butyl]-3-phenylprop-2-enamide |
|---|
| Description | ST 198 is an orally active D3R antagonist. ST 198 can block the expression of nicotine-induced CPP at doses selective for D3R. ST 198 can be used for the research of neurological disease[1]. |
|---|---|
| Related Catalog | |
| In Vitro | ST 198 可以在对 D3R 具有选择性的剂量下阻断尼古丁诱导的 CPP 的表达[1]。 |
| In Vivo | ST 198 (p.o.; 3, 30, 100 mg/kg) 抑制尼古丁 CPPs 的表达[1]。 Animal Model: Rats[1]. Dosage: 3, 30, 100 mg/kg Administration: p.o Result: Displayed nicotine-induced CPP. |
| References |
| Molecular Formula | C22H26N2O |
|---|---|
| Molecular Weight | 334.45 |
| Exact Mass | 334.20500 |
| PSA | 35.83000 |
| LogP | 4.43270 |